Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
Several gene therapies are or will soon be in late-stage human trials. One of them could be the first to get FDA approval for sale in the U.S.
In 2012, genomics tiptoed into the doctor’s office, gene therapy rose again, and man and machine united.
Regulatory approval of a gene therapy treatment in Europe could spark broader patient access to the technology.